EDITORIAL
Case of the PONS study
 
More details
Hide details
1
Population Health Research Institute, McMaster University, Hamilton, Canada
 
Ann Agric Environ Med. 2011;18(2):279–280
 
ABSTRACT
Poland is one of the most interesting countries in Central and Eastern Europe, where at the beginning of the 90’s major amazing favourable health changes were observed aft er 30 years of increases in cardiovascular mortality between 1960-1990 among adults. In Poland (and neighboring countries), the cardiovascular transformation began with a 20-year delay in comparison to Western Europe. In Poland, cardiovascular morbidity and mortality continuoues to decline, as is the case in western European countries and in North America. The cause of this signifi cant decline of CVD sustained over the last 20 years, seems to be strongly connected with changes in diet, especially rapid changes in vegetable fat consumption. For this reason, but most importantly due to my long and very good collaboration with Polish cardiologists, when in 2005 I began developing study teams for the PURE study, I thought of Poland.
 
REFERENCES (5)
1.
Zatoński WA, McMichael AJ, Powles JW. Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ 1998;316(7137):1047-51.
 
2.
Zatoński WA, Willett W. Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ 2005;331:187- 8.
 
3.
Yusuf S, Flather M, Pogue J, Hunt D, Varigos J, Piegas L, Avezum A, Anderson J, Keltai M, Budaj A, Fox K, Ceremuzynski L. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet. 1998;352(9127):507-14.
 
4.
Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. Th e Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal infl uences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009;158(1):1-7.
 
5.
Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, Lopez-Jaramillo P, Oguz A, Rahman O, Swidan H, Yusoff K, Zatonski W, Rosengren A, Teo KK. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middleincome, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;378(9798):1231-43.
 
eISSN:1898-2263
ISSN:1232-1966